NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
The Place of the Lipid Specialist in the Medical Community
A medical specialist is a provider/clinician with expertise beyond the generalist. The National Lipid Association (NLA) partners with the American Board of Clinical Lipidology (ABCL)…
To Stop the Rise in Cardiovascular Deaths, We Must Take Action outside the Clinic
As healthcare professionals, we devote our careers to service. We hope to make a lasting impact for each of our patients. Our advancements in treating…
The ABCs of Lipoprotein(a)
In recent years, lipoprotein(a) [Lp(a)] has been recognized as a prevalent risk factor for cardiovascular disease. It is estimated that ~20% of the global population…
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society…
Aspirin Use and Lipoprotein(a) Genotypes in Primary Prevention
Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Although approximately 20% of the population has elevated Lp(a) levels (≥ 50 mg/dL…
Lipid Treatment for Uninsured Populations with Severe Hypercholesterolemia
The characterization and treatment of severe hypercholesterolemia among patients within large health systems have been studied extensively.1-6 However, little is known about the burden of…
Pharmacotherapy in Obesity: Not Just for Three Months
Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that are grossly underutilized. Obesity is…
When Is It Reasonable to Consider Withholding Lipid Lowering Therapy?
Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth consideration in some individuals. These…